Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143076 |
| CAS No | NA |
| Mol.F. | C22H23ClN8O |
| Mol.Wt. | 450.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143077 |
| CAS No | NA |
| Mol.F. | C26H30ClN7O2 |
| Mol.Wt. | 508.02 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143078 |
| CAS No | NA |
| Mol.F. | C23H24ClN7O2 |
| Mol.Wt. | 465.94 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143079 |
| CAS No | NA |
| Mol.F. | C22H21ClN10O |
| Mol.Wt. | 476.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143080 |
| CAS No | NA |
| Mol.F. | C22H21ClN6O2 |
| Mol.Wt. | 465.90 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143081 |
| CAS No | NA |
| Mol.F. | C24H23N5O6S |
| Mol.Wt. | 509.54 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143082 |
| CAS No | NA |
| Mol.F. | C24H21N5O6S |
| Mol.Wt. | 507.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143083 |
| CAS No | NA |
| Mol.F. | C31H29N5O7S |
| Mol.Wt. | 615.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143084 |
| CAS No | NA |
| Mol.F. | C24H25N5O5S |
| Mol.Wt. | 495.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143085 |
| CAS No | NA |
| Mol.F. | C23H21N5O6S |
| Mol.Wt. | 495.51 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143086 |
| CAS No | NA |
| Mol.F. | C14H11N3O6 |
| Mol.Wt. | 317.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143087 |
| CAS No | NA |
| Mol.F. | C9H8N2O5 |
| Mol.Wt. | 224.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143088 |
| CAS No | NA |
| Mol.F. | C11H12N2O5 |
| Mol.Wt. | 252.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143089 |
| CAS No | NA |
| Mol.F. | C8H6N2O5 |
| Mol.Wt. | 210.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143090 |
| CAS No | NA |
| Mol.F. | C10H10N2O5 |
| Mol.Wt. | 238.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143091 |
| CAS No | NA |
| Mol.F. | C13H16N2O9 |
| Mol.Wt. | 344.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |